MARKET

MGTX

MGTX

Meiragtx Holdings Plc
NASDAQ
11.01
+0.60
+5.76%
Opening 11:18 06/18 EDT
OPEN
10.62
PREV CLOSE
10.41
HIGH
11.18
LOW
10.61
VOLUME
529.79K
TURNOVER
--
52 WEEK HIGH
11.85
52 WEEK LOW
6.07
MARKET CAP
1.02B
P/E (TTM)
-7.3942
1D
5D
1M
3M
1Y
5Y
1D
MeiraGTx Shareholders Back Board Slate and Auditor Renewal
TipRanks · 2d ago
Weekly Report: what happened at MGTX last week (0608-0612)?
Weekly Report · 3d ago
Weekly Report: what happened at MGTX last week (0601-0605)?
Weekly Report · 06/08 09:14
MeiraGTx posts investor deck outlining late-stage gene therapy pipeline, manufacturing platform
PUBT · 06/05 13:54
Acting FDA head vows to block political interference, Endpoint News says
TipRanks · 06/04 18:16
MeiraGTx publishes corporate deck outlining late-stage gene therapy pipeline, manufacturing platform
PUBT · 06/04 15:43
FDA issues draft guidance to help accelerated cell, gene therapies for patients
TipRanks · 06/02 14:03
Weekly Report: what happened at MGTX last week (0525-0529)?
Weekly Report · 06/01 09:15
More
About MGTX
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company. It has a pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It is focused on vivo delivery of vectorized biologic therapeutics addressing unmet needs in prevalent disorders, including severe forms of xerostomia, neurodegenerative diseases and ocular diseases, including inherited retinal diseases (IRDs), and large degenerative ocular diseases. The Company’s product pipeline includes Botaretigene Sparoparvovec for the treatment of X-linked Retinitis Pigmentosa; AAV-hAQP1 for the treatment of Radiation-Induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-Associated Retinal Dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of Achromatopsia; AAV-AIPL1 for the treatment of LCA4, and others.

Webull offers MeiraGTx Holdings PLC stock information, including NASDAQ: MGTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MGTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MGTX stock methods without spending real money on the virtual paper trading platform.